These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27842546)

  • 1. Optimization of construct design and fermentation strategy for the production of bioactive ATF-SAP, a saporin based anti-tumoral uPAR-targeted chimera.
    Errico Provenzano A; Posteri R; Giansanti F; Angelucci F; Flavell SU; Flavell DJ; Fabbrini MS; Porro D; Ippoliti R; Ceriotti A; Branduardi P; Vago R
    Microb Cell Fact; 2016 Nov; 15(1):194. PubMed ID: 27842546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pichia pastoris as a host for secretion of toxic saporin chimeras.
    Lombardi A; Bursomanno S; Lopardo T; Traini R; Colombatti M; Ippoliti R; Flavell DJ; Flavell SU; Ceriotti A; Fabbrini MS
    FASEB J; 2010 Jan; 24(1):253-65. PubMed ID: 19786581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-tumoral potential of the saporin-based uPAR-targeting chimera ATF-SAP.
    Zuppone S; Assalini C; Minici C; Bertagnoli S; Branduardi P; Degano M; Fabbrini MS; Montorsi F; Salonia A; Vago R
    Sci Rep; 2020 Feb; 10(1):2521. PubMed ID: 32054892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino-terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: internalization is toxin mediated.
    Fabbrini MS; Carpani D; Bello-Rivero I; Soria MR
    FASEB J; 1997 Nov; 11(13):1169-76. PubMed ID: 9367352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.
    Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC
    Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conjugate between human urokinase and saporin, a type-1 ribosome-inactivating protein, is selectively cytotoxic to urokinase receptor-expressing cells.
    Cavallaro U; del Vecchio A; Lappi DA; Soria MR
    J Biol Chem; 1993 Nov; 268(31):23186-90. PubMed ID: 8226837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosolic immunization allows the expression of preATF-saporin chimeric toxin in eukaryotic cells.
    Fabbrini MS; Carpani D; Soria MR; Ceriotti A
    FASEB J; 2000 Feb; 14(2):391-8. PubMed ID: 10657995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
    Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
    Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
    DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, purification, and biological characterization of the amino-terminal fragment of urokinase in Pichia pastoris.
    Li J; Lin Y; Zhuang H; Hua ZC
    J Microbiol Biotechnol; 2013 Sep; 23(9):1197-205. PubMed ID: 23751561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
    Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
    Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocytosis of a chimera between human pro-urokinase and the plant toxin saporin: an unusual internalization mechanism.
    Ippoliti R; Lendaro E; Benedetti PA; Torrisi MR; Belleudi F; Carpani D; Soria MR; Fabbrini MS
    FASEB J; 2000 Jul; 14(10):1335-44. PubMed ID: 10877826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study of anti-metastasis effect of urokinase amino-terminal fragment gene on human breast cancer cells].
    Zhu F; Xing G; He F
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):115-7. PubMed ID: 11783013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and functional characterization of a recombinant targeted toxin with an uPA cleavable linker in Pichia pastoris.
    Zhu Wh; Sun Mn; Wang Ys; Sun DJ; Zhang Sx
    Protein Expr Purif; 2011 Apr; 76(2):184-9. PubMed ID: 21144903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase receptor (uPAR) ligand based recombinant toxins for human cancer therapy.
    de Virgilio M; Silvestris F
    Curr Pharm Des; 2011; 17(19):1979-83. PubMed ID: 21711232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and purification of recombinant ATF-mellitin, a new type fusion protein targeting ovarian cancer cells, in P. pastoris.
    Su M; Chang W; Zhang K; Cui M; Wu S; Xu T
    Oncol Rep; 2016 Feb; 35(2):1179-85. PubMed ID: 26718643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soapwort Saporin L3 Expression in Yeast, Mutagenesis, and RNA Substrate Specificity.
    Yuan H; Du Q; Sturm MB; Schramm VL
    Biochemistry; 2015 Jul; 54(29):4565-74. PubMed ID: 26091305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc phthalocyanine conjugated with the amino-terminal fragment of urokinase for tumor-targeting photodynamic therapy.
    Chen Z; Xu P; Chen J; Chen H; Hu P; Chen X; Lin L; Huang Y; Zheng K; Zhou S; Li R; Chen S; Liu J; Xue J; Huang M
    Acta Biomater; 2014 Oct; 10(10):4257-68. PubMed ID: 24969665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.